These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32470604)

  • 1. A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.
    Lin YC; Cheng CY; Chen CP; Cheng SH; Chang SY; Hsueh PR
    Int J Infect Dis; 2020 Jul; 96():464-466. PubMed ID: 32470604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

  • 3. Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.
    Huang PI; Lin TC; Liu FC; Ho YJ; Lu JW; Lin TY
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33028028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Rijkers G; Murk JL; Wintermans B; van Looy B; van den Berge M; Veenemans J; Stohr J; Reusken C; van der Pol P; Reimerink J
    J Infect Dis; 2020 Sep; 222(8):1265-1269. PubMed ID: 32726417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Hung IF; Cheng VC; Li X; Tam AR; Hung DL; Chiu KH; Yip CC; Cai JP; Ho DT; Wong SC; Leung SS; Chu MY; Tang MO; Chen JH; Poon RW; Fung AY; Zhang RR; Yan EY; Chen LL; Choi CY; Leung KH; Chung TW; Lam SH; Lam TP; Chan JF; Chan KH; Wu TC; Ho PL; Chan JW; Lau CS; To KK; Yuen KY
    Lancet Infect Dis; 2020 Sep; 20(9):1051-1060. PubMed ID: 32539986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
    Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
    J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
    Yin S; Tong X; Huang A; Shen H; Li Y; Liu Y; Wu C; Huang R; Chen Y
    J Infect; 2020 Sep; 81(3):e31-e32. PubMed ID: 32622905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020.
    Chirathaworn C; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Palakawong Na Ayuthaya T; Brukesawan C; Chaiwanichsiri D; Intharasongkroh D; Wanlapakorn N; Chansaenroj J; Puenpa J; Yorsaeng R; Thitithanyanont A; Kitphati R; Mungaomklang A; Nagavajara P; Poovorawan Y
    PLoS One; 2020; 15(10):e0236905. PubMed ID: 33119712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
    Wang QJ; Yao YZ; Song JS; Wang Q; Xu LY; Bao ZJ; Mao DW; Zhou JH; Zhang ZE; Wang Y; Li YW; Wang HP; Li L; Pan HY; Zhang GQ; Li SB
    BMC Infect Dis; 2020 Nov; 20(1):818. PubMed ID: 33167900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SARS-CoV-2 viral RNA in fecal samples.
    Mesoraca A; Margiotti K; Viola A; Cima A; Sparacino D; Giorlandino C
    Virol J; 2020 Jun; 17(1):86. PubMed ID: 32605577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
    Yamagishi T; Ohnishi M; Matsunaga N; Kakimoto K; Kamiya H; Okamoto K; Suzuki M; Gu Y; Sakaguchi M; Tajima T; Takaya S; Ohmagari N; Takeda M; Matsuyama S; Shirato K; Nao N; Hasegawa H; Kageyama T; Takayama I; Saito S; Wada K; Fujita R; Saito H; Okinaka K; Griffith M; Parry AE; Barnetson B; Leonard J; Wakita T
    J Infect Dis; 2020 Sep; 222(7):1098-1102. PubMed ID: 32691828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.
    Fierz W; Walz B
    Front Immunol; 2020; 11():1120. PubMed ID: 32582200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
    Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.